Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
MDGN201 TARGTEPO
Avalo Therapeutics
Anemia of End Stage Renal Disease
1 trial -
METFORMIN
Istituto Gentili S.r.l.
bone sarcoma
1 trial -
METFORMIN , The placebo components are propylene glycol, neoPCLO/W, fenonip XB and purified water., METHYL AMINOLEVULINATE
The George Institute
Actinic keratoses
1 trial -
METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE HYDROGEN SUCCINATE, METHYLPREDNISOLONE , METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE
Pari Pharma GmbH
NEUROENDOCRINE CELLS HYPERPLASIA OF INFANCY
1 trial -
MHS-1031
CATALYST PHARMACEUTICALS, INC.
Gastroesophageal Reflux
1 trial -
MIE
The First People's Hospital of Lianyungang
Esophageal Cancer
1 trial -
MK-1167
Merck KGaA, Darmstadt, Germany
Alzheimer Disease
1 trial -
MK-2214
Merck KGaA, Darmstadt, Germany
Early Alzheimer's Disease
1 trial -
MK-3475A
Merck Sharp and Dohme
Relapsed or Refractory Classical Hodgkinβs Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)
1 trial -
MK-6194
Merck KGaA, Darmstadt, Germany
Systemic Lupus Erythematosus
1 trial -
MOVIPREP, MaaT033, MOVIPREP Orange, poudre pour solution buvable, Placebo is an inert coated capsule with no microbiota (active substance) inside. It is composed of a mix of coloring agents and partially pre-gelatinized corn starch in Hydroxypropyl methylcellulose capsule.
Pari Pharma GmbH
AXIAL SPONDYLOARTHRITIS
1 trial -
MSCAT-THAC Placebo, Allogeneic Mesenchymal stromal cells derived from adipose tissue thawed and cultured
Pari Pharma GmbH
Systemic sclerosis
1 trial -
MYCOPHENOLIC ACID , PREDNISONE, MYCOPHENOLATE SODIUM, PREDNISONE, MYCOPHENOLATE SODIUM, Placebo 0 mg hard gelatin capsule size 0 and size 2, (placebo to LNP023), METHYLPREDNISOLONE , IPTACOPAN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LNP023, Placebo to prednisone
Novartis Pharmaceuticals
Lupus Nephritis Class III-IV, +/- V
1 trial -
MaaT033 capsule
Regeneron UK Limited
NSCLC (Advanced Non-small Cell Lung Cancer)
1 trial -
Matched placebo for test product, SAR444336
Sanofi-aventis Healthcare Pty Ltd
Digestive system diseases
1 trial -
Matching Placebo tablets without active substance, BIIB122
Biogen
Parkinson's Disease
1 trial -
Matching placebo tablets without active substance, BI 706321, BI 706321, BI 706321, STELARA 130 mg concentrate for solution for infusion, STELARA 90 mg solution for injection in pre-filled pen
Boehringer Ingelheim
Crohn`s Disease (CD)
1 trial -
Medical Collagen Membrane with MSC
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Wounds
1 trial -
Melphalan
Ultragenyx UK Limited
Amyloidosis
1 trial -
MenQuadfi solution for injection Meningococcal Group A, C, W and Y conjugate vaccine, DANICOPAN, Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNA, component, adsorbed)
Lacuna Pharma Pty Ltd
Chronic spontaneous urticaria
1 trial -
Mesenchymal progenitor cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial -
Metformin Zentiva 500 mg Filmtabletten
The George Institute
Multidrug rezistant pulmonary tuberculosis
1 trial -
Metronidazole 500 mg / 100 ml Intravenous Infusion, Metronidazole 500mg/100ml Solution for Infusion, Aztreonam and Avibactam (1.5g/0.5g) Powder for Concentrate for Solution for Infusion, Metronidazole
Pfizer Australia Pty Ltd
Sepsis, Suspected or Confirmed Infections Due to Gram-Negative Pathogens Requiring Intravenous Antibiotic Treatment, Complicated Urinary Tract Infection, Blood Stream Infection, Hospital-acquired pneumonia or ventilator-associated pneumonia, Complicated Intra-abdominal Infection
1 trial -
Mibavademab
Regeneron UK Limited
Functional Hypothalamic Amenorrhea (FHA)
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources